| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 31.414 | 43.205 | 36.609 | 40.650 | 59.198 |
| Total Income - EUR | - | - | - | 0 | 2.627 | 45.184 | 57.270 | 50.719 | 56.381 | 73.868 |
| Total Expenses - EUR | - | - | - | 2.960 | 2.576 | 39.918 | 51.433 | 49.132 | 47.270 | 54.580 |
| Gross Profit/Loss - EUR | - | - | - | -2.960 | 51 | 5.266 | 5.837 | 1.587 | 9.111 | 19.289 |
| Net Profit/Loss - EUR | - | - | - | -2.960 | 51 | 4.963 | 5.453 | 1.271 | 8.696 | 18.732 |
| Employees | - | - | - | 0 | 0 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Equimedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 129 | 107.615 | 97.551 | 80.870 | 64.776 | 48.973 | 40.592 |
| Current Assets | - | - | - | 115.369 | 204.830 | 202.252 | 104.328 | 9.634 | 22.981 | 25.623 |
| Inventories | - | - | - | 0 | 0 | 3.273 | 0 | 0 | 3.630 | 42 |
| Receivables | - | - | - | 103.530 | 99.428 | 98.071 | 2.433 | 8.271 | 16.884 | 25.035 |
| Cash | - | - | - | 11.839 | 105.402 | 100.908 | 101.894 | 1.363 | 2.467 | 546 |
| Shareholders Funds | - | - | - | -2.917 | 9.792 | 14.569 | 19.699 | 19.152 | 21.406 | 31.873 |
| Social Capital | - | - | - | 43 | 12.644 | 12.404 | 12.129 | 12.167 | 12.130 | 12.062 |
| Debts | - | - | - | 14.973 | 205.424 | 202.723 | 99.159 | 3.752 | 11.716 | 10.065 |
| Income in Advance | - | - | - | 103.442 | 98.812 | 83.169 | 67.259 | 53.358 | 39.130 | 24.924 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Equimedica S.r.l.